With regard to the government’s response to the COVID-19 pandemic and its reliance on the National Advisory Committee on Immunization (NACI) for their “independent, expert advice” (source: Order Paper question Q-2554): (a) in 2020 and 2021, what specific studies demonstrated that the COVID-19 vaccines would prevent (i) all, (ii) any, transmission of SARS-CoV-2; (b) what specific studies demonstrated that the COVID-19 vaccines were ineffective or would not completely prevent transmission of SARS-CoV-2; (c) in 2020 and 2021, what specific data was provided by the manufacturers of the approved COVID-19 vaccines in Canada that demonstrated that the COVID-19 vaccines were effective in preventing transmission of SARS-CoV-2; (d) with respect to informed consent in 2021, how was the uncertainty or “unknown” evidence around “the effectiveness against virus transmission, and long-term effectiveness against infection and severe disease” communicated to the Canadian public and medical professionals administering the vaccines; (e) without certainty that the vaccine would prevent transmission, what was the rationale provided to the Office of the Prime Minister from the Public Health Agency of Canada, Health Canada or NACI in support of the following measures in relation to only unvaccinated healthy individuals presenting with no symptoms (i) PCR testing before entering the country, (ii) quarantining individuals before entering the country, (iii) showing one’s vaccine status through a vaccine passport, (iv) preventing their travelling on federally-regulated transportation; (f) who advised the Office of the Prime Minister about the uncertainty of the COVID-19 vaccines with respect to its inability to prevent transmission of SARS-CoV2 and when; (g) what was the source of the messaging used by (i) the Chief Public Health Officer, (ii) the Deputy Chief Public Health officer, (iii) the Chief Medical Officer of Health Canada, (iv) the Minister of Health, (v) the Prime Minister, (vi) other government or public health officials, to state that COVID-19 vaccination would protect others, implying it stopped viral transmission; and (h) who approved the messaging in (g)?
In the House of Commons on September 16th, 2024. See this statement in context.